HomeInsights
INDUSTRY:
Pharma
TOPIC:
Regulatory & Legal, Products & Services, Manufacturers & Providers
TITLE:
EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-8 July 2016
BRIEF:
At its July meeting, the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) concluded a safety referral on one medicine, and initiated three new safety referrals.
LEGAL IMPLICATIONS:
BUSINESS IMPLICATIONS:
